Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
Details
Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: All rights reserved
UNIL restricted access
State: Public
Version: Final published version
License: All rights reserved
Serval ID
serval:BIB_A3E713D81992
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
Journal
Journal of the European Academy of Dermatology and Venereology
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
06/2021
Peer-reviewed
Oui
Volume
35
Number
6
Pages
e362-e365
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Publication Status: ppublish
Abstract
Since the introduction of active vaccination against SARS-CoV-2 infection, there has been a debate about the risk of developing severe allergic or anaphylactic reactions among individuals with a history of allergy. Indeed, rare cases of severe allergic reactions have been reported in the United Kingdom and North America. By february 2021 a rate of 4,5 severe allergic reactions occurred among 1 million patients vaccinated with the mRNA-based COVID-19 vaccines, which is higher than the generally expected rate of severe allergic reactions to vaccinations of around 1 in 1 million.
Keywords
Anaphylaxis, COVID-19, COVID-19 Vaccines, Dermatitis, Atopic/prevention & control, Humans, SARS-CoV-2, Vaccines
Pubmed
Web of science
Open Access
Yes
Create date
30/03/2021 10:46
Last modification date
31/10/2023 7:09